'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Vaginal Cancer to Oncology Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Vaginal Cancer to Oncology Clinical Trials 20
Clinical Trials by Phase in E7 Countries 21
Clinical Trials in E7 Countries by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status 25
Clinical Trials by End Point Status 27
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Vaginal Cancer Therapeutics Clinical Trials 32
Prominent Drugs 34
Clinical Trial Profile Snapshots 35
Appendix 86
Abbreviations 86
Definitions 86
Research Methodology 87
Secondary Research 87
About GlobalData 87
Contact Us 88
Disclaimer 88
Source 88
List of Tables
Vaginal Cancer Therapeutics, Global, Clinical Trials by Region, 2018* 7
Vaginal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Vaginal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Vaginal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
Vaginal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Vaginal Cancer Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Vaginal Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 14
Vaginal Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 15
Proportion of Vaginal Cancer to Oncology Clinical Trials, G7 Countries (%), 2018* 16
Vaginal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Vaginal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Vaginal Cancer to Oncology Clinical Trials, E7 Countries (%), 2018* 20
Vaginal Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 21
Vaginal Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 22
Vaginal Cancer Therapeutics, Global, Clinical Trials by Phase, 2018* 23
Vaginal Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 24
Vaginal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2018* 26
Vaginal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2018* 27
Vaginal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 28
Vaginal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 29
Vaginal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 31
Vaginal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 33
Vaginal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 34
List of Figures
Vaginal Cancer Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Vaginal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Vaginal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Vaginal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
Vaginal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Vaginal Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Vaginal Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 14
Vaginal Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 15
Proportion of Vaginal Cancer to Oncology Clinical Trials, G7 Countries (%), 2018* 16
Vaginal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Vaginal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Vaginal Cancer to Oncology Clinical Trials, E7 Countries (%), 2018* 20
Vaginal Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 21
Vaginal Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 22
Vaginal Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2018* 23
Vaginal Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 24
Vaginal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2018* 25
Vaginal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2018* 27
Vaginal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 28
Vaginal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 29
Vaginal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 30
Vaginal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 32
Vaginal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 34
GlobalData Methodology 87